Colorectal Cancer Screening in the United States: What Is the Best FIT?

The article focuses on the use of fecal immunochemical testing (FIT) in colorectal cancer (CRC) screening in the U.S. Topics include the release of an examination of evidence by the U.S. Multi-Society Task Force on the use of FIT for CRC screening in average-risk populations, available CRC screening test in the U.S., and provision under the Patient Protection and Affordable Care Act on preventive services endorsed by the U.S. Preventive Services Task Force including CRC screening.